0001209191-21-046700.txt : 20210714 0001209191-21-046700.hdr.sgml : 20210714 20210714184758 ACCESSION NUMBER: 0001209191-21-046700 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210712 FILED AS OF DATE: 20210714 DATE AS OF CHANGE: 20210714 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Crockett Nigel CENTRAL INDEX KEY: 0001788580 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38916 FILM NUMBER: 211091267 MAIL ADDRESS: STREET 1: C/O BICYCLE THERAPEUTICS PLC STREET 2: B900, BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BICYCLE THERAPEUTICS plc CENTRAL INDEX KEY: 0001761612 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 BUSINESS ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT BUSINESS PHONE: 011441223261503 MAIL ADDRESS: STREET 1: B900 BABRAHAM RESEARCH CAMPUS CITY: CAMBRIDGE STATE: X0 ZIP: CB22 3AT FORMER COMPANY: FORMER CONFORMED NAME: BICYCLE THERAPEUTICS Ltd DATE OF NAME CHANGE: 20181212 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-07-12 0 0001761612 BICYCLE THERAPEUTICS plc BCYC 0001788580 Crockett Nigel C/O BICYCLE THERAPEUTICS PLC B900, BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT UNITED KINGDOM 0 1 0 0 Chief Business Officer Ordinary Shares 2021-07-12 4 M 0 4331 11.66 A 4331 D Ordinary Shares 2021-07-12 4 M 0 1723 9.82 A 6054 D Ordinary Shares 2021-07-12 4 M 0 974 15.36 A 7028 D Ordinary Shares 2021-07-12 4 S 0 7028 32.03 D 0 D Ordinary Shares 2021-07-13 4 M 0 40426 11.66 A 40426 D Ordinary Shares 2021-07-13 4 M 0 19256 9.82 A 59682 D Ordinary Shares 2021-07-13 4 M 0 13019 15.36 A 72701 D Ordinary Shares 2021-07-13 4 S 0 69580 32.41 D 3121 D Ordinary Shares 2021-07-13 4 S 0 3121 33.09 D 0 D Employee Stock Option (right to buy) 11.66 2021-07-12 4 M 0 4331 0.00 D 2029-09-26 Ordinary Shares 4331 103086 D Employee Stock Option (right to buy) 9.82 2021-07-12 4 M 0 1723 0.00 D 2030-01-02 Ordinary Shares 1723 58006 D Employee Stock Option (right to buy) 15.36 2021-07-12 4 M 0 974 0.00 D 2030-02-21 Ordinary Shares 974 43783 D Employee Stock Option (right to buy) 11.66 2021-07-13 4 M 0 40426 0.00 D 2029-09-26 Ordinary Shares 40426 62660 D Employee Stock Option (right to buy) 9.82 2021-07-13 4 M 0 19256 0.00 D 2030-01-02 Ordinary Shares 19256 38750 D Employee Stock Option (right to buy) 15.36 2021-07-13 4 M 0 13019 0.00 D 2030-02-21 Ordinary Shares 13019 30764 D Shares sold pursuant to a Rule 10b5-1 trading plan. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.26 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4). The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.99 inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.00 to $33.50 inclusive. 25% of the shares underlying this option shall vest on September 26, 2020, and the remaining shall vest in 36 equal monthly installments. This option shall vest one-fourth (1/4) of the total number of shares under option on January 2, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter. This option shall vest one-fourth (1/4) of the total number of shares under option on February 21, 2021 and the remaining shares in 36 equal monthly installments at the end of each calendar month thereafter. /s/ Lee Kalowski, Attorney-in-Fact 2021-07-14